Capital Expenditures for Insmed (INSM)
According to Insmed's latest reported financial statements, the company's current capital expenditures (TTM) is $62.56M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
INSM
Currently viewingCapital ExpendituresSwitch metric
Latest period
$62.56M
YoY change
+48.5%
5Y CAGR
+36.7%
Peak year (2019)
$42.27M
Cumulative capital expenditures
$180.60M
CapEx history chart for Insmed (INSM) from 1999 to 2025
CapEx history table for Insmed (INSM) from 1999 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $32.56M | +48.5% | ||
| 2024 | $21.92M | +65.0% | ||
| 2023 | $13.29M | +34.5% | ||
| 2022 | $9.88M | +35.5% | ||
| 2021 | $7.29M | +6.8% | ||
| 2020 | $6.82M | -83.9% | ||
| 2019 | $42.27M | +185.3% | ||
| 2018 | $14.81M | +393.6% | ||
| 2017 | $3.00M | -28.5% | ||
| 2016 | $4.20M | +21.6% | ||
| 2015 | $3.45M | -35.5% | ||
| 2014 | $5.35M | +547.8% | ||
| 2013 | $826,000 | +184.8% | ||
| 2012 | $290,000 | -70.4% | ||
| 2011 | $979,000 | -85.5% | ||
| 2010 | $6.73M | — | ||
| 2009 | $0 | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | -100.0% | ||
| 2006 | $5.02M | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | -100.0% | ||
| 2002 | $251,000 | 0.0% | ||
| 2001 | $251,000 | -80.6% | ||
| 2000 | $1.29M | +1083.1% | ||
| 1999 | $109,378 | — |
CapEx values are taken from Insmed's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Insmed (INSM) capital expenditures totalled $32.56M – surged 48.5% year-over-year.
Over 2020–2025 (5 years), Insmed capital expenditures expanded at a +36.7% compound annual rate, sustaining 5 straight years of year-over-year growth.
Between 2019 and 2025, Insmed capital expenditures declined 23.0%, falling from $42.27M to $32.56M.
Across the available history, capital expenditures reached its high of $42.27M in 2019 and its low of $0 in 2003.
Insmed (INSM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Insmed Capital Expenditures by Year
Insmed Capital Expenditures 2025: $32.56M
Insmed capital expenditures in 2025 was $32.56M, surged 48.5% from 2024.
Insmed Capital Expenditures 2024: $21.92M
Insmed capital expenditures in 2024 was $21.92M, surged 65.0% from 2023.
Insmed Capital Expenditures 2023: $13.29M
Insmed capital expenditures in 2023 was $13.29M, surged 34.5% from 2022.
Insmed Capital Expenditures 2022: $9.88M
Insmed capital expenditures in 2022 was $9.88M, surged 35.5% from 2021.
Insmed Capital Expenditures 2021: $7.29M
Insmed capital expenditures in 2021 was $7.29M.
See more financial history for Insmed (INSM).
Sector peers — CapEx
Companies in the same sector as Insmed, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Insmed's capital expenditures?
- Latest reported capital expenditures for Insmed (INSM) is $62.56M (period ending December 31, 2025).
How has Insmed capital expenditures changed year-over-year?
- Insmed (INSM) capital expenditures changed +48.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Insmed capital expenditures?
- Insmed (INSM) capital expenditures compound annual growth rate is +36.7% over the most recent 5 years available.
When did Insmed capital expenditures hit its highest annual value?
- Insmed capital expenditures reached its highest annual value of $42.27M in 2019.
What was Insmed capital expenditures in 2024?
- Insmed (INSM) capital expenditures in 2024 was $21.92M.
What was Insmed capital expenditures in 2025?
- Insmed (INSM) capital expenditures in 2025 was $32.56M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INSM Overview
Company profile, financial tools, and key metrics
INSM Revenue Counter
Earns $19.23 every second. See per minute, hour, and day.
INSM Earnings Counter
Loses −$40.49 per second. See per minute, hour, and day.
INSM Economic Scale
Exceeds Micronesia, Fed. Sts.'s GDP. Compare with world economies.
INSM What If Invested
What if you had invested $1,000? See historical returns from any date.
INSM How It Makes Money
Discover visual breakdown of $606.42M in revenue — where it comes from and where it goes.
INSM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INSM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INSM Daily Price Character
Explosive · 46.7% historical win rate (green days). Streaks & record days.
INSM Buybacks
See repurchase history & metrics. Shareholder yield & SBC comparison.
INSM Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.